PH22410A - Transdermal treatment for pain and inflammation with 2-amino-3-aroylbenzeneacetic acids, salts and esters - Google Patents

Transdermal treatment for pain and inflammation with 2-amino-3-aroylbenzeneacetic acids, salts and esters

Info

Publication number
PH22410A
PH22410A PH34409A PH34409A PH22410A PH 22410 A PH22410 A PH 22410A PH 34409 A PH34409 A PH 34409A PH 34409 A PH34409 A PH 34409A PH 22410 A PH22410 A PH 22410A
Authority
PH
Philippines
Prior art keywords
inflammation
pain
esters
salts
amino
Prior art date
Application number
PH34409A
Other languages
English (en)
Inventor
Richard George Poser
Original Assignee
Robins Co Inc A H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robins Co Inc A H filed Critical Robins Co Inc A H
Publication of PH22410A publication Critical patent/PH22410A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PH34409A 1985-10-28 1986-10-24 Transdermal treatment for pain and inflammation with 2-amino-3-aroylbenzeneacetic acids, salts and esters PH22410A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/792,269 US4683242A (en) 1985-10-28 1985-10-28 Transdermal treatment for pain and inflammation with 2-amino-3-aroylbenzeneacetic acids, salts and esters

Publications (1)

Publication Number Publication Date
PH22410A true PH22410A (en) 1988-08-26

Family

ID=25156312

Family Applications (1)

Application Number Title Priority Date Filing Date
PH34409A PH22410A (en) 1985-10-28 1986-10-24 Transdermal treatment for pain and inflammation with 2-amino-3-aroylbenzeneacetic acids, salts and esters

Country Status (12)

Country Link
US (1) US4683242A (xx)
EP (1) EP0221753B1 (xx)
JP (1) JPH07116027B2 (xx)
AT (1) ATE71358T1 (xx)
AU (1) AU596813B2 (xx)
DE (1) DE3683350D1 (xx)
ES (1) ES2039354T3 (xx)
GR (1) GR3004278T3 (xx)
HU (1) HU197210B (xx)
IE (1) IE59229B1 (xx)
PH (1) PH22410A (xx)
ZA (1) ZA867988B (xx)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3620674A1 (de) * 1986-06-20 1987-12-23 Nattermann A & Cie Salbe zur behandlung von hauterkrankungen
US4782089A (en) * 1986-08-26 1988-11-01 A. H. Robins Company, Incorporated 2-amino-3-aroyl-gamma-oxobenzenebutanoic acids and esters
US4910225A (en) * 1988-01-27 1990-03-20 Senju Pharmaceutical Co., Ltd. Locally administrable therapeutic composition for inflammatory disease
US5016615A (en) * 1990-02-20 1991-05-21 Riverside Research Institute Local application of medication with ultrasound
WO1995032715A1 (en) 1994-05-27 1995-12-07 Neptune Pharmaceutical Corporation Nitric oxide donor composition and method for treatment of anal disorders
US5475034A (en) * 1994-06-06 1995-12-12 Alcon Laboratories, Inc. Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders
DE19631220C2 (de) * 1996-08-02 2000-03-23 Beiersdorf Ag Schaumförmige oder schäumbare Zubereitungen mit einem Gehalt an grenzflächenaktiven Substanzen und Elektrolyten
US6066671A (en) * 1997-12-19 2000-05-23 Alcon Laboratories, Inc. Treatment of GLC1A glaucoma with 3-benzoyl-phenylacetic acids, esters, or amides
US6646001B2 (en) 1997-12-19 2003-11-11 Alcon Manufacturing, Ltd. Use of non-steroidal anti-inflammatory agents in combination with prostaglandin FP receptor agonists to treat glaucoma and ocular hypertension
US20060015058A1 (en) * 1998-01-08 2006-01-19 Kellogg Scott C Agents and methods for enhancement of transdermal transport
US8287483B2 (en) * 1998-01-08 2012-10-16 Echo Therapeutics, Inc. Method and apparatus for enhancement of transdermal transport
US7066884B2 (en) * 1998-01-08 2006-06-27 Sontra Medical, Inc. System, method, and device for non-invasive body fluid sampling and analysis
US20040171980A1 (en) 1998-12-18 2004-09-02 Sontra Medical, Inc. Method and apparatus for enhancement of transdermal transport
AR030345A1 (es) * 2000-08-14 2003-08-20 Alcon Inc Metodo de tratamiento de desordenes relacionados con angiogenesis
AR030346A1 (es) * 2000-08-14 2003-08-20 Alcon Inc Metodo de tratamiento de desordenes neurodegenerativos de la retina y cabeza de nervio optico
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US7186745B2 (en) 2001-03-06 2007-03-06 Astrazeneca Ab Indolone derivatives having vascular damaging activity
US6646003B2 (en) 2001-04-02 2003-11-11 Alcon, Inc. Method of treating ocular inflammatory and angiogenesis-related disorders of the posterior segment of the eye using an amide derivative of flurbiprofen or ketorolac
JP2005525408A (ja) * 2002-05-03 2005-08-25 アルコン，インコーポレイテッド アンフェナクまたはネパフェナクを用いる血管内皮増殖因子媒介性血管障害の処置方法
JP4500261B2 (ja) 2003-01-21 2010-07-14 千寿製薬株式会社 ２−アミノ−３−（４−ブロモベンゾイル）フェニル酢酸含有水性液剤
US20030187072A1 (en) * 2003-02-14 2003-10-02 Kapin Michael A. Method of treating angiogenesis-related disorders
US8224414B2 (en) * 2004-10-28 2012-07-17 Echo Therapeutics, Inc. System and method for analyte sampling and analysis with hydrogel
TWI358290B (en) 2004-12-02 2012-02-21 Alcon Inc Topical nepafenac formulations
PT1937276E (pt) 2005-10-12 2013-02-21 Besins Healthcare Luxembourg Gel de testosterona melhorado e método para a sua utilização
US7432069B2 (en) * 2005-12-05 2008-10-07 Sontra Medical Corporation Biocompatible chemically crosslinked hydrogels for glucose sensing
TW200812575A (en) * 2006-04-28 2008-03-16 Alcon Inc Formulations containing amide derivatives of carboxylic acid NSAIDs for topical administration to the eye
FR2909876A1 (fr) * 2006-12-19 2008-06-20 Galderma Res & Dev S N C Snc Utilisation du nepafenac ou ses derives pour le traitement de desordres dermatologiques
US20090105245A1 (en) * 2006-12-21 2009-04-23 Bingaman David P Methods for treating macular edema and ocular angiogenesis using an anti-inflammatory agent and a receptor tyrosine kinase inhibitor
US20080153819A1 (en) * 2006-12-21 2008-06-26 Bingaman David P Methods for treating macular edema and pathologic ocular angiogenesis using a neuroprotective agent and a receptor tyrosine kinase inhibitor
US20080153818A1 (en) * 2006-12-21 2008-06-26 Bingaman David P Methods for preventing inflammation during surgery
US8812071B2 (en) * 2007-03-07 2014-08-19 Echo Therapeutics, Inc. Transdermal analyte monitoring systems and methods for analyte detection
NZ580997A (en) * 2007-04-27 2011-08-26 Echo Therapeutics Inc Dermal abrasion device with feedback electrode to deliver data on skin thickness and removable abrasion heads
GB0919757D0 (en) 2009-11-12 2009-12-30 Johnson Matthey Plc Polymorphs of bromfenac sodium and methods for preparing bromfenac sodium polymorphs
GB2484843A (en) * 2009-10-15 2012-04-25 Johnson Matthey Plc Polymorphs of Bromfenac sodium
US8299295B2 (en) 2009-10-15 2012-10-30 Johnson Matthey Public Limited Company Polymorphs of bromfenac sodium and methods for preparing bromfenac sodium polymorphs
CN104151182B (zh) * 2014-06-16 2016-03-30 广东众生药业股份有限公司 一种溴芬酸钠倍半水合物的制备方法
CN104177272B (zh) * 2014-06-16 2016-04-06 广东众生药业股份有限公司 一种溴芬酸钠的制备方法
CN106404952B (zh) * 2016-08-31 2019-06-11 辰欣佛都药业（汶上）有限公司 一种溴芬酸钠滴眼液有关物质的测定方法
CN115093340B (zh) * 2022-06-27 2024-05-03 辰欣药业股份有限公司 一种溴芬酸钠倍半水合物的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE400966B (sv) 1975-08-13 1978-04-17 Robins Co Inc A H Forfarande for framstellning av 2-amino-3-(eller 5-)bensoyl-fenylettiksyror
JPS53130634A (en) * 1977-04-20 1978-11-14 Hisamitsu Pharmaceut Co Inc Novel 2-(3-phenoxyphenyl) propionic acid ester derivatives
JPS596287B2 (ja) * 1980-11-28 1984-02-10 日東電工株式会社 医薬製剤
US4503073A (en) * 1981-01-07 1985-03-05 A. H. Robins Company, Incorporated 2-Amino-3-(alkylthiobenzoyl)-phenylacetic acids
IL64724A0 (en) 1981-02-17 1982-03-31 Robins Co Inc A H 2-amino-3-(halobenzoyl)-methylphenylacetic acids and esters and salts thereof and pharmaceutical compositions containing them
JPS5883622A (ja) * 1981-11-10 1983-05-19 Hisamitsu Pharmaceut Co Inc 消炎鎮痛ゲル状クリーム剤
WO1986002636A1 (en) * 1984-10-30 1986-05-09 Takeda Chemical Industries, Ltd. Benzoic acid derivatives and process for their preparation

Also Published As

Publication number Publication date
JPH07116027B2 (ja) 1995-12-13
HU197210B (en) 1989-03-28
ES2039354T3 (es) 1996-07-16
AU6444786A (en) 1987-04-30
IE862811L (en) 1987-04-28
ATE71358T1 (de) 1992-01-15
ZA867988B (en) 1987-06-24
DE3683350D1 (de) 1992-02-20
EP0221753B1 (en) 1992-01-08
HUT42948A (en) 1987-09-28
GR3004278T3 (xx) 1993-03-31
EP0221753A2 (en) 1987-05-13
EP0221753A3 (en) 1988-04-27
AU596813B2 (en) 1990-05-17
US4683242A (en) 1987-07-28
IE59229B1 (en) 1994-01-26
JPS62126124A (ja) 1987-06-08

Similar Documents

Publication Publication Date Title
PH22410A (en) Transdermal treatment for pain and inflammation with 2-amino-3-aroylbenzeneacetic acids, salts and esters
PH23867A (en) Method of treating parkinson's disease using indolone derivatives
EP0285278A3 (en) Method of treating anxiety with tetrahydrobenzûc,d¨indole-6-carboxamides
HK1005849A1 (en) Use of l-carnitine derivatives for the manufacture of a medicament for the therapeutical treatment of peripheral neuropathies
IL78954A (en) Hydantoin spirocondensed with benzopyran and quinoline derivatives and pharmaceutical compositions containing them
HUT70757A (en) Pharmaceutical compositions for treating skin disorders
AU5684086A (en) Use of an aqueous chlorite matrix solution for the treatment of tumors
PL304335A1 (en) Drug for treating disorders in the form of compulsive ideas and movements
GB8823605D0 (en) Therapeutic agents
AU1494395A (en) The use of deoxyspergualin for preparing a pharmaceutical for treating hyperreactive inflammatory diseases
EP0258048A3 (en) 2-amino-3-aroyl-gamma-oxobenzenebutanoic acids and esters
AU7931487A (en) Therapeutic treatment of abnormal cell growth with follicle regulatory protein
YU15301A (sh) PRIMENA R (+)- alfa-(2,3-DIMETOKSIFENIL)-1-[2-(4-FLUOROFENIL) ETIL] -4-PIPERIDINMETANOLA ZA LECENJE POREMEĆAJA SPAVANJA